465 related articles for article (PubMed ID: 8295285)
1. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
Viberti G; Mogensen CE; Groop LC; Pauls JF
JAMA; 1994 Jan; 271(4):275-9. PubMed ID: 8295285
[TBL] [Abstract][Full Text] [Related]
2. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Laffel LM; McGill JB; Gans DJ
Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus.
Cook J; Daneman D; Spino M; Sochett E; Perlman K; Balfe JW
J Pediatr; 1990 Jul; 117(1 Pt 1):39-45. PubMed ID: 2196359
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
Mathiesen ER; Hommel E; Giese J; Parving HH
BMJ; 1991 Jul; 303(6794):81-7. PubMed ID: 1860008
[TBL] [Abstract][Full Text] [Related]
5. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
Sjølie AK; Chaturvedi N; Fuller J
Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
[TBL] [Abstract][Full Text] [Related]
6. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
Lancet; 1997 Jun; 349(9068):1787-92. PubMed ID: 9269212
[TBL] [Abstract][Full Text] [Related]
7. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.
Diabetologia; 1996 May; 39(5):587-93. PubMed ID: 8739919
[TBL] [Abstract][Full Text] [Related]
8. Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group.
Trevisan R; Tiengo A
Am J Hypertens; 1995 Sep; 8(9):876-83. PubMed ID: 8541002
[TBL] [Abstract][Full Text] [Related]
9. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of captopril on glomerular hyperfiltration in normoalbuminuric normotensive insulin-dependent diabetic patients.
de Azevedo MJ; Ramos OL; Gross JL
Horm Metab Res; 1997 Oct; 29(10):516-9. PubMed ID: 9405980
[TBL] [Abstract][Full Text] [Related]
11. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
[TBL] [Abstract][Full Text] [Related]
12. Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom.
BMJ; 1995 Oct; 311(7011):973-7. PubMed ID: 7580637
[TBL] [Abstract][Full Text] [Related]
13. Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patients.
Hansen KW; Klein F; Christensen PD; Sørensen K; Andersen PH; Møller J; Pedersen EB; Christiansen JS; Mogensen CE
Diabete Metab; 1994; 20(5):485-93. PubMed ID: 7859897
[TBL] [Abstract][Full Text] [Related]
14. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
Ratzmann KP; Raskovic M; Schimke E
Dtsch Med Wochenschr; 1994 Jun; 119(22):796-800. PubMed ID: 8205941
[TBL] [Abstract][Full Text] [Related]
15. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
Parving HH; Hommel E; Smidt UM
BMJ; 1988 Oct; 297(6656):1086-91. PubMed ID: 3143437
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
Sasongko TH; Nagalla S; Ballas SK
Cochrane Database Syst Rev; 2013 Mar; (3):CD009191. PubMed ID: 23543572
[TBL] [Abstract][Full Text] [Related]
17. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
Ravid M; Savin H; Jutrin I; Bental T; Katz B; Lishner M
Ann Intern Med; 1993 Apr; 118(8):577-81. PubMed ID: 8452322
[TBL] [Abstract][Full Text] [Related]
18. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
Ahmad J; Siddiqui MA; Ahmad H
Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
[TBL] [Abstract][Full Text] [Related]
19. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).
Marre M; Lievre M; Chatellier G; Mann JF; Passa P; Ménard J;
BMJ; 2004 Feb; 328(7438):495. PubMed ID: 14960504
[TBL] [Abstract][Full Text] [Related]
20. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
Ficociello LH; Perkins BA; Silva KH; Finkelstein DM; Ignatowska-Switalska H; Gaciong Z; Cupples LA; Aschengrau A; Warram JH; Krolewski AS
Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
